ISASS: Improved 1-year outcome with Superion and X-STOP devices for lumbar spinal stenosis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Prospective, randomized, multicenter study comparing the clinical outcomes of two minimally invasive interspinous devices for the treatment of lumbar spinal stenosis
416 patients were randomized to receive either the Superion or X-STOP interspinous systems in minimally invasive surgery for symptomatic treatment of lumbar spinal stenosis. The objective of the study was to determine if there was a difference in clinical outcomes of the two devices at 12 months of a 5 year trial. The results at 1 year follow-up indicated that both treatment devices significantly improved clinical outcome compared to preoperative values, and that there was no difference between groups at any follow-up assessment. Rate of re-operation also did not significantly differ between groups. Future assessment in this study will determine if any differences exist between the two interspinous systems.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics